UBS Group
SFE

UBS Group’s Safeguard Scientifics, Inc. SFE Stock Holding History

UBS Group’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-182
Closed -$143 – 10424
2023
Q4 		$143 Sell
182
-84
-32% -$85 ﹤0.01% 8874
2023
Q3 		$266 Sell
266
-299
-53% -$389 ﹤0.01% 8639
2023
Q2 		$932 Hold
565
– – ﹤0.01% 8064
2023
Q1 		$972 Sell
565
-4,382
-89% -$12.1K ﹤0.01% 8867
2022
Q4 		$15.3K Buy
4,947
+4,382
+776% +$14.7K ﹤0.01% 7990
2022
Q3 		$2K Sell
565
-8
-1% -$32 ﹤0.01% 9834
2022
Q2 		$2K Buy
573
+383
+202% +$1.6K ﹤0.01% 9681
2022
Q1 		$1K Sell
190
-28
-13% -$170 ﹤0.01% 10010
2021
Q4 		$2K Hold
218
– – ﹤0.01% 9862
2021
Q3 		$2K Sell
218
-2,496
-92% -$20K ﹤0.01% 9027
2021
Q2 		$21K Sell
2,714
-2,254
-45% -$15.4K ﹤0.01% 7289
2021
Q1 		$34K Buy
4,968
+306
+7% +$2.22K ﹤0.01% 6910
2020
Q4 		$29K Buy
4,662
+1,964
+73% +$12.3K ﹤0.01% 6669
2020
Q3 		$15K Sell
2,698
-5,836
-68% -$34.8K ﹤0.01% 6547
2020
Q2 		$60K Sell
8,534
-13,835
-62% -$87.5K ﹤0.01% 5713
2020
Q1 		$124K Sell
22,369
-2,853
-11% -$25.5K ﹤0.01% 5096
2019
Q4 		$277K Buy
25,222
+3,279
+15% +$37.5K ﹤0.01% 5354
2019
Q3 		$249K Buy
21,943
+11,293
+106% +$135K ﹤0.01% 5074
2019
Q2 		$129K Buy
10,650
+863
+9% +$10.1K ﹤0.01% 5216
2019
Q1 		$106K Sell
9,787
-15,272
-61% -$155K ﹤0.01% 5027
2018
Q4 		$216K Buy
25,059
+8,384
+50% +$73.1K ﹤0.01% 4904
2018
Q3 		$156K Buy
16,675
+446
+3% +$4.84K ﹤0.01% 5238
2018
Q2 		$208K Buy
16,229
+2,703
+20% +$34.9K ﹤0.01% 4913
2018
Q1 		$166K Sell
13,526
-532
-4% -$6.47K ﹤0.01% 4905
2017
Q4 		$157K Sell
14,058
-3,977
-22% -$50.9K ﹤0.01% 5087
2017
Q3 		$241K Buy
18,035
+125
+0.7% +$1.54K ﹤0.01% 4720
2017
Q2 		$214K Sell
17,910
-1,260
-7% -$14.8K ﹤0.01% 4704
2017
Q1 		$243K Sell
19,170
-2,711
-12% -$34.1K ﹤0.01% 4539
2016
Q4 		$294K Sell
21,881
-12,164
-36% -$150K ﹤0.01% 4504
2016
Q3 		$441K Sell
34,045
-3,063
-8% -$40.6K ﹤0.01% 3996
2016
Q2 		$464K Buy
37,108
+4,366
+13% +$58.6K ﹤0.01% 3947
2016
Q1 		$434K Buy
32,742
+25
+0.1% +$315 ﹤0.01% 3883
2015
Q4 		$475K Sell
32,717
-1,332
-4% -$21.5K ﹤0.01% 3994
2015
Q3 		$529K Buy
34,049
+3,377
+11% +$60.6K ﹤0.01% 3860
2015
Q2 		$596K Buy
30,672
+23,818
+348% +$437K ﹤0.01% 3972
2015
Q1 		$124K Sell
6,854
-497
-7% -$9.2K ﹤0.01% 5256
2014
Q4 		$146K Buy
+7,351
New +$142K ﹤0.01% 5328

Other funds holding SFE

CP
Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
FWM
FSA Wealth Management Needham, Massachusetts $273M AUM 16.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS Group's SFE Position: Q1 2024 in Review

UBS Group sold out of Safeguard Scientifics, Inc. (SFE) in Q1 2024, closing a stake of 182 shares — an estimated $143 sold.

UBS Group first reported a position in SFE in Q4 2014 and held it in 37 quarters. The position peaked at $596K in Q2 2015. 4 funds tracked by Wall St. Rank hold SFE as of Q1 2024.

  • UBS Group reported no remaining Safeguard Scientifics, Inc. position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 182 Safeguard Scientifics, Inc. shares in Q1 2024, an estimated $143.
  • UBS Group first reported a position in Safeguard Scientifics, Inc. in Q4 2014 and held it in 37 quarters.
  • UBS Group's Safeguard Scientifics, Inc. position peaked at $596K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.